Why it was recalled
Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss
Product description
B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Street, Suite #1 NYC, NY 10040.
Lot numbers, UPCs & expiration codes
Lot #: 20213, Exp 12/22/2016.
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0424-2015
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Dec 19, 2014
- FDA report date
- Apr 1, 2015
- Quantity
- UNKNOWN
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Bethel Nutritional Consulting, Inc
Original FDA data
Every field from FDA enforcement report D-0424-2015, exactly as published.
Show all FDA fields
- City
- New York
- State
- NY
- Status
- Terminated
- Country
- United States
- Event ID
- 70096
- Address
- 599 W 190th St Ste 1
- Code information
- Lot #: 20213, Exp 12/22/2016.
- Postal code
- 10040-3577
- Report date
- Apr 1, 2015
- Product type
- Drugs
- Recall number
- D-0424-2015
- Classification
- Class II
- Recalling firm
- Bethel Nutritional Consulting, Inc
- Product quantity
- UNKNOWN
- Termination date
- Jun 4, 2018
- Reason for recall
- Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Street, Suite #1 NYC, NY 10040.
- Distribution pattern
- Nationwide
- Recall initiation date
- Dec 19, 2014
- Initial firm notification
- Press Release
- Center classification date
- Mar 24, 2015